Skip to main content
SpringerLink
Log in

Telehealth in the UK: pound foolish?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The Whole System Demonstrator telehealth trial, funded by the Department of Health. The effects of telehealth on QOL and psychological improvements in this trial have previously been reported; see PharmacoEconomics & Outcomes News 673 p5; 801085654

  2. incremental cost-effectiveness ratio

References

  1. Henderson C, et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ : 22 Mar 2013. Available from: URL: http://dx.doi.org/10.1136/bmj.f1035.

  2. Roehr B. Telehealth can be beneficial when used properly, say experts. BMJ 346: 26 Mar 2013. Available from: URL: http://dx.doi.org/10.1136/bmj.f1995.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Telehealth in the UK: pound foolish?. PharmacoEcon Outcomes News 675, 4 (2013). https://doi.org/10.1007/s40274-013-0273-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0273-1

Search

Navigation